Access the full text.
Sign up today, get DeepDyve free for 14 days.
Mi-Hye Kwon, Deok-Hoon Kong, Se-Hui Jung, I. Suh, Young-Myeong Kim, K. Ha (2011)
Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma.Analytical chemistry, 83 6
Jae-Wan Jung, Se-Hui Jung, Je-Ok Yoo, I. Suh, Young-Myeong Kim, K. Ha (2009)
Label-free and quantitative analysis of C-reactive protein in human sera by tagged-internal standard assay on antibody arrays.Biosensors & bioelectronics, 24 5
Xinrong Yang, Yang Xu, G. Shi, Jia Fan, Jian Zhou, Yuan Ji, Hui-Chuan Sun, S. Qiu, Bing Yu, Q. Gao, Yi-Zhou He, Weng-Zhen Qin, Rongxin Chen, Guo-huan Yang, Bing Wu, Qing Lu, Zhi-quan Wu, Zhao-You Tang (2008)
Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative ResectionClinical Cancer Research, 14
J.S. Olshaker B. Clyne (1999)
The C-reactive proteinJ. Emerg. Med., 17
F. Wang-Johanning, Ming Li, F. Esteva, K. Hess, Bingnan Yin, K. Rycaj, Joshua Plummer, J. Garza, S. Ambs, G. Johanning (2014)
Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early‐stage breast cancerInternational Journal of Cancer, 134
N. Wild, H. Andres, W. Rollinger, Friedemann Krause, P. Dilba, M. Tacke, J. Karl (2010)
A Combination of Serum Markers for the Early Detection of Colorectal CancerClinical Cancer Research, 16
M. Gunter, R. Stolzenberg-Solomon, A. Cross, M. Leitzmann, S. Weinstein, R. Wood, J. Virtamo, P. Taylor, D. Albanes, R. Sinha (2006)
A prospective study of serum C-reactive protein and colorectal cancer risk in men.Cancer research, 66 4
D. Trichopoulos, T. Psaltopoulou, P. Orfanos, A. Trichopoulou, P. Boffetta (2006)
Plasma C-Reactive Protein and Risk of Cancer: A Prospective Study from GreeceCancer Epidemiology Biomarkers & Prevention, 15
Seounghee Lee, J. Choe, Hong-Kyu Kim, J. Sung (2011)
High-Sensitivity C-Reactive Protein and CancerJournal of Epidemiology, 21
T. Uenishi, Shoji Kubo, K. Hirohashi, Hiroaki Tanaka, T. Shuto, Takatsugu Yamamoto, Shuhei Nishiguchi (2003)
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancerBritish Journal of Cancer, 88
A. Chaturvedi, N. Caporaso, H. Katki, Hui-lee Wong, N. Chatterjee, Sharon Pine, S. Chanock, J. Goedert, E. Engels (2010)
C-reactive protein and risk of lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 16
Deok-Hoon Kong, Jae-Wan Jung, Keun Na, Seul‐Ki Jeong, Y. Paik, Sehee Jung, I. Suh, Young-Myeong Kim, K. Ha (2012)
Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease.Analytica chimica acta, 718
B. Coventry, M. Ashdown, M. Quinn, S. Markovic, S. Yatomi-Clarke, A. Robinson (2009)
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?Journal of Translational Medicine, 7
H. Kamel, Hiba Al-Amodi (2016)
Cancer Biomarkers
A. Au, M. Vasel, Sabrina Kraft, Carla Sens, N. Hackl, A. Marx, P. Stroebel, J. Hennenlotter, T. Todenhöfer, A. Stenzl, S. Schott, H. Sinn, A. Wetterwald, J. Bermejo, M. Cecchini, I. Nakchbandi (2013)
Circulating Fibronectin Controls Tumor Growth 1 , 2
R. Siegel, Jiemin Ma, Zhaohui Zou, A. Jemal (2014)
Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 64
I. Kushner S. Black (2004)
C-reactive ProteinJ. Biol. Chem., 279
Kangseung Lee, Se-Hui Jung, Deok-Hoon Kong, Byeong-Moon Hwang, E. Han, Seoung-Woo Park, Jae Park, Young-Myeong Kim, K. Ha (2013)
Comparative characterization of direct and indirect substrate probes for on-chip transamidating activity assay of transglutaminases.Journal of biotechnology, 168 4
A. Grothey, P. Heistermann, S. Philippou, R. Voigtmann (1998)
Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.British Journal of Cancer, 77
S. Skates, N. Horick, Yin-hua Yu, Feng-ji Xu, A. Berchuck, L. Havrilesky, H. Bruijn, A. Zee, R. Woolas, I. Jacobs, Zhen Zhang, R. Bast (2004)
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 20
P. Wagner, M. Verma, S. Srivastava (2004)
Challenges for Biomarkers in Cancer DetectionAnnals of the New York Academy of Sciences, 1022
A. Gautier, Scheidegger Jj (1957)
[The C-reactive protein].Schweizerische medizinische Wochenschrift, 87 28
Richard Moore, A. Brown, M. Miller, S. Skates, W. Allard, T. Verch, M. Steinhoff, G. Messerlian, P. DiSilvestro, C. Granai, R. Bast (2008)
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.Gynecologic oncology, 108 2
M. Alam, F. Al-Jenoobi, A. Al-Mohizea (2015)
High-throughput ultra-performance LC-MS-MS method for analysis of diclofenac sodium in rabbit plasma.Journal of chromatographic science, 53 1
F. Leung, A. Soosaipillai, V. Kulasingam, E. Diamandis (2012)
CUB and zona pellucida-like domain-containing protein 1 (CUZD1): a novel serological biomarker for ovarian cancer.Clinical biochemistry, 45 18
(2009)
a potential treatment targeting tool? J
S. Holdenrieder, P. Stieber, V. Liska, V. Treska, O. Topolcan, J. Dreslerova, V. Matějka, J. Finek, L. Holubec (2012)
Cytokeratin serum biomarkers in patients with colorectal cancer.Anticancer research, 32 5
D. Alexiou, A. Karayiannakis, Konstantinos Syrigos, Andrew Zbar, A. Kremmyda, I. Bramis, Christos Tsigris (2001)
Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery.European journal of cancer, 37 18
K. Allin, S. Bojesen, B. Nordestgaard (2009)
Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 13
D.F. Hayes N.L. Henry (2012)
Cancer biomarkersMol. Oncol., 6
Abstract Selecting normal control samples is critical for the identification and evaluation of serum biomarker proteins; however, currently few inclusion parameters have been identified. In this paper, we investigated whether serum C-reactive protein (CRP) levels are a suitable inclusion parameter to define normal controls. We analyzed serum α-fetoprotein (AFP), cytokeratin 19 fragment (CYFRA 21-1), intercellular adhesion molecule 1 (ICAM-1), and fibronectin expression levels from normal individuals (n=97) and patients with hepatocellular carcinoma (n=36), lung cancer (n=50), and colorectal cancer (n=30). Receiver operating characteristic (ROC) analysis of the biomarker proteins was performed using four different control groups (C1–C4) with increasing serum CRP levels. The biomarker expression levels were higher in all three sets of cancer patients when compared with control groups C1 through C3. The AUC, sensitivity, and specificity values of the biomarkers dramatically decreased with increasing CRP levels in the control groups. These results suggest that the serum CRP level affects downstream ROC analysis, and that CRP levels could be used as a control inclusion parameter to define normal samples for identifying and evaluating serum cancer biomarkers.
BioChip Journal – Springer Journals
Published: Mar 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.